As Kriya plans to move its gene therapies into the clinic, the firm adds $150 million from its Series C financing. The added Series C financing round brings Kriya Therapeutics’ funding to a total of $430 million in a bid to advance the firm’s gene therapy efforts. According to the company, the proceeds from this round will support moving Kriya’s pipeline of undisclosed gene therapies into the clinic, as well as the advancement of its engineering and manufacturing platforms. “We…
Pfizer is confident its North Carolina injectables plant “will go back to life” after suffering tornado damage but warns of near-term revenue challenges. A tornado ripped through Rocky Mount, North Carolina last month forcing a halt to operations at Pfizer’s sterile injectables facility. While no staff was injured, the plant – which produces more than 200 million units annually – suffered significant damage. “It was severe,” Pfizer’s CEO Albert Bourla said on an earnings call this week. “The damage was…